Literature DB >> 16710813

Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population.

D Ziegler1, C Zentai, S Perz, W Rathmann, B Haastert, C Meisinger, H Löwel.   

Abstract

Both cardiac autonomic dysfunction adn cardiovascular risk factors are related to and excess risk of mortality. We sought to determine whether the major cardiovascular risk factors are associated with diminished heart rate variability (HRV), prolonged QTc interval, or increased QT dispersion (QTD). Male (n = 1030) and female (n = 957) subjects, aged 55-74 years, who participated in the population-based MONICA Augsburg survey 1989/90 were assessed for the presence of cardiovascular risk factors such as diabetes, hypertension, obesity, dyslipidemia, smoking, and low physical activity. Lowest quartiles for time domain indexes of HRV (SD of R-R intervals [SDNN], max-min difference), QTc > 440 ms, and QTD > 60 ms determined from 12-lead resting ECG were used as cutpoints. In men, after adjustment for age and alcohol consumption, significant independent determinants for the lowest quartiles of SDNN were diabetes, obesity, and smoking. Independent contributors to prolonged QTc were hypertension, obesity, smoking, and low physical activity, whereas for increased QTD it was only hypertension. In women, diabetes was the only contributor to low SDNN, and hypertension was the only determinant of prolonged QTc. In conclusion, diabetes is the primary determinant of reduced HRV in the general population, while hypertension is the primary contributor to prolonged QTc in both sexes. However, obesity and smoking contribute to autonomic dysfunction in men but not women. Thus, a selectivity and sex-related differences exist among the various cardiovascular risk factors as to their influence on autonomic dysfunction.

Entities:  

Mesh:

Year:  2006        PMID: 16710813     DOI: 10.1055/s-2006-924083

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  23 in total

Review 1.  What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.

Authors:  Rodica Pop-Busui
Journal:  J Cardiovasc Transl Res       Date:  2012-05-30       Impact factor: 4.132

2.  Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey.

Authors:  Dan Ziegler; Andreas Voss; Wolfgang Rathmann; Alexander Strom; Siegfried Perz; Michael Roden; Annette Peters; Christa Meisinger
Journal:  Diabetologia       Date:  2015-02-28       Impact factor: 10.122

Review 3.  Physiology and immunology of the cholinergic antiinflammatory pathway.

Authors:  Kevin J Tracey
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

4.  Clinical risk model assessment for cardiovascular autonomic dysfunction in the general Chinese population.

Authors:  L Zhang; Z-H Tang; F Zeng; Z Li; L Zhou; Y Li
Journal:  J Endocrinol Invest       Date:  2015-01-03       Impact factor: 4.256

Review 5.  The vagus nerve and the inflammatory reflex--linking immunity and metabolism.

Authors:  Valentin A Pavlov; Kevin J Tracey
Journal:  Nat Rev Endocrinol       Date:  2012-12       Impact factor: 43.330

Review 6.  Neural circuitry and immunity.

Authors:  Valentin A Pavlov; Kevin J Tracey
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 7.  Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment.

Authors:  Akif Serhat Balcıoğlu; Haldun Müderrisoğlu
Journal:  World J Diabetes       Date:  2015-02-15

8.  Multivariate short-term heart rate variability: a pre-diagnostic tool for screening heart disease.

Authors:  Andreas Heitmann; Thomas Huebner; Rico Schroeder; Siegfried Perz; Andreas Voss
Journal:  Med Biol Eng Comput       Date:  2010-12-08       Impact factor: 2.602

9.  Cardiovascular autonomic function in Cushing's syndrome.

Authors:  F Fallo; P Maffei; A Dalla Pozza; M Carli; P Della Mea; M Lupia; F Rabbia; N Sonino
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

Review 10.  Exercise therapy in type 2 diabetes.

Authors:  Stephan F E Praet; Luc J C van Loon
Journal:  Acta Diabetol       Date:  2009-05-29       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.